Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients

Area of Science:

• Neuroscience
• Stem Cell Biology
• Genetics

Background:

• X-linked adrenoleukodystrophy (X-ALD) lacks suitable animal models and accessible human oligodendrocytes for research.
• Induced pluripotent stem cells (iPSCs) offer a promising cellular model for studying X-ALD.

Purpose of the Study:

• To generate and characterize X-ALD iPSCs for modeling disease mechanisms.
• To investigate disease-relevant phenotypes in differentiated X-ALD cells.

Main Methods:

• Generated iPSCs from patients with childhood cerebral ALD (CCALD) and adrenomyeloneuropathy (AMN).
• Differentiated iPSCs into oligodendrocytes and neurons.
• Evaluated very long chain fatty acid (VLCFA) levels and ABCD2 gene expression.

Main Results:

• X-ALD iPSCs differentiated normally into oligodendrocytes and neurons.
• VLCFA levels significantly increased in X-ALD oligodendrocytes post-differentiation, with higher accumulation in CCALD than AMN.
• Lovastatin or 4-phenylbutyrate treatment reduced VLCFA accumulation via ABCD2 upregulation.

Conclusions:

• The X-ALD iPSC model accurately recapitulates VLCFA accumulation in oligodendrocytes, a key disease event.
• This model provides insights into X-ALD pathogenesis and subtype differences.
• X-ALD oligodendrocytes derived from iPSCs are valuable for developing new therapeutics.